Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study

noticia |

Booth C.M., Siemens D.R., Li G., Peng Y., Tannock I.F., Kong W., Berman D.M., Mackillop W.J.

Cancer 2014 120:11 (1630-1638)

BACKGROUND Practice guidelines recommend neoadjuvant chemotherapy (NACT) for bladder cancer. However, the evidence in support of adjuvant chemotherapy (ACT) is less robust. Here we describe whether the evidence of efficacy for NACT/ACT was sufficient to change clinical practice and whether the efficacy demonstrated in clinical trials was translated into effectiveness in the general population. METHODS Electronic records of treatment were linked to the population-based Ontario Cancer Registry to identify all patients with bladder cancer treated with cystectomy in Ontario 1994-2008. Utilization of NACT/ACT was compared across 1994-1998, 1999-2003, and 2004-2008. Logistic regression was used to analyze factors associated with NACT/ACT. Cox model and propensity score analyses were used to explore the association between ACT and survival…(vermás)


1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)